1. Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. (June 2022) Authors: Houser, Katherine V.; Gaudinski, Martin R.; Happe, Myra; Narpala, Sandeep; Verardi, Raffaello; Sarfo, Edward K.; Corrigan, Angela R.; Wu, Richard; Rothwell, Ro Shauna; Novik, Laura; Hendel, Cynthia S.; Gordon, Ingelise J.; Berkowitz, Nina M.; Cartagena, Cora Trelles; Widge, Alicia T.; Coates, Emi... Journal: EClinicalMedicine Issue: Volume 48(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗